PNRC2 encodes a coactivator which interacts with nuclear receptors using a proline-rich sequence (Zhou and Chen, 2001), and it may be targeted by mir-23a-3p to further promote the progression of renal cell carcinoma (Quan et al., 2019). This evidence concerns the gene PNRC2 and hereditary clear cell renal cell carcinoma.